Gwo Xi Stem Cells (TPEx: 6704) is a biopharmaceutical company dedicated to developing innovative stem cell & exosomes therapies. We have successfully advanced several stem cell medicines and MSC-derived exosomes. Our mesenchymal stem cell-derived exosomes have been officially granted an INCI name, paving the way for expansion into the anti-aging and cosmetic markets. In addition, we are currently conducting clinical trials for four novel stem cell-based drug candidates that address unmet medical needs, with two candidates in Phase III development. We are actively seeking strategic partners for licensing and commercialization. We are now looking for partners across CDMO, OEM, and distribution channels.